All Relations between Autism Spectrum Disorder and cannabinoids

Reference Sentence Publish Date Extraction Date Species
Rick Wilhiam de Camargo, Lin\\xc3\\xa9rio Ribeiro de Novais J\\xc3\\xbanior, Larissa Mendes da Silva, Vicente Meneguzzo, Guilherme Cabreira Daros, Marina Goulart da Silva, Rafael Mariano de Bitencour. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacology, biochemistry, and behavior vol issue 2022 36379443 implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: a literature review. 2022-11-15 2022-11-21 Not clear
Riccardo Bortoletto, Marco Colizz. Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis. Healthcare (Basel, Switzerland) vol 10 issue 8 2022 36011210 being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. 2022-08-26 2022-08-29 Not clear
Riccardo Bortoletto, Marco Colizz. Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis. Healthcare (Basel, Switzerland) vol 10 issue 8 2022 36011210 thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. 2022-08-26 2022-08-29 Not clear
Aviad Schnapp, Moria Harel, Dalit Cayam-Rand, Hanoch Cassuto, Lola Polyansky, Adi Ara. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines vol 10 issue 7 2022 35884990 a placebo-controlled trial of cannabinoid treatment for disruptive behavior in children and adolescents with autism spectrum disorder: effects on sleep parameters as measured by the cshq. 2022-07-27 2022-08-08 Not clear
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health vol 19 issue 9 2022 35565034 in this regard, the endocannabinoid system has been suggested to modulate neural circuits during the early stage of neurodevelopment, with implications for both autism and psychosis. 2022-05-14 2022-06-13 Not clear
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health vol 19 issue 9 2022 35565034 here, we systematically review all human and animal studies examining the endocannabinoid system and its biobehavioral correlates in the association between autism and psychosis. 2022-05-14 2022-06-13 Not clear
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health vol 19 issue 9 2022 35565034 studies indicate overlapping biobehavioral aberrancies between autism and schizophrenia, subject to correction by modulation of the endocannabinoid system. 2022-05-14 2022-06-13 Not clear
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health vol 19 issue 9 2022 35565034 interestingly, a developmental and transgenerational trajectory between autism and schizophrenia is supported by evidence that exogenous alteration of the endocannabinoid system promotes progression to inheritable psychosis phenotypes in the context of biobehavioral autism vulnerability. 2022-05-14 2022-06-13 Not clear
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health vol 19 issue 9 2022 35565034 several clinical implications follow from evidence of a developmental continuum between autism and psychosis as a function of the endocannabinoid system dysregulation. 2022-05-14 2022-06-13 Not clear
Mariana Babayeva, Haregewein Assefa, Paramita Basu, Zvi Loew. Autism and associated disorders: cannabis as a potential therapy. Frontiers in bioscience (Elite edition) vol 14 issue 1 2022 35320905 therefore, the endocannabinoid system represents a potential target for the development of a novel autism therapy. 2022-03-23 2022-04-14 Not clear
Susanna Pietropaolo, Giovanni Marsican. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models. Neuroscience and biobehavioral reviews vol issue 2021 34813825 the role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: lessons from behavioral studies on mouse models. 2022-02-04 2022-01-13 Not clear
Mingyang Zou, Yu Liu, Shu Xie, Luxi Wang, Dexin Li, Ling Li, Feng Wang, Yujue Zhang, Wei Xia, Caihong Sun, Lijie W. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open biology vol 11 issue 2 2021 33529552 alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. 2022-02-03 2022-01-13 Not clear
Michelle De Pol, Nathan J Koll. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies. Psychiatry research vol 306 issue 2021 34775294 endocannabinoid markers in autism spectrum disorder: a scoping review of human studies. 2021-12-07 2022-01-13 Not clear
Susanna Pietropaolo, Giovanni Marsican. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models. Neuroscience and biobehavioral reviews vol issue 2021 34813825 the role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: lessons from behavioral studies on mouse models. 2021-11-30 2022-01-13 Not clear
Tangfeng Su, Yu Yan, Qiang Li, Jiacai Ye, Lei Pe. Endocannabinoid System Unlocks the Puzzle of Autism Treatment Frontiers in psychiatry vol 12 issue 2021 34744824 endocannabinoid system unlocks the puzzle of autism treatment autism spectrum disorder (asd) is a serious neurodevelopmental disorder and characterized by early childhood-onset impairments in social interaction and communication, restricted and repetitive patterns of behavior or interests. 2021-11-10 2022-01-13 Not clear
Mingyang Zou, Yu Liu, Shu Xie, Luxi Wang, Dexin Li, Ling Li, Feng Wang, Yujue Zhang, Wei Xia, Caihong Sun, Lijie W. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open biology vol 11 issue 2 2021 33529552 alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. 2021-10-14 2022-01-13 Not clear
William Fyke, Marika Premoli, Victor Echeverry Alzate, Jos\\xc3\\xa9 A L\\xc3\\xb3pez-Moreno, Valerie Lemaire-Mayo, Wim E Crusio, Giovanni Marsicano, Markus W\\xc3\\xb6hr, Susanna Pietropaol. Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder. Autism research : official journal of the International Society for Autism Research vol 14 issue 9 2021 34173729 clinical and preclinical findings have suggested a role of the endocannabinoid system (ecs) in the etiopathology of autism spectrum disorder (asd). 2021-09-27 2022-01-13 Not clear
Adi Aran, Moria Harel, Hanoch Cassuto, Lola Polyansky, Aviad Schnapp, Nadia Wattad, Dorit Shmueli, Daphna Golan, F Xavier Castellano. Cannabinoid treatment for autism: a proof-of-concept randomized trial. Molecular autism vol 12 issue 1 2021 33536055 cannabinoid treatment for autism: a proof-of-concept randomized trial. 2021-09-24 2022-01-13 Not clear
Adi Aran, Moria Harel, Hanoch Cassuto, Lola Polyansky, Aviad Schnapp, Nadia Wattad, Dorit Shmueli, Daphna Golan, F Xavier Castellano. Cannabinoid treatment for autism: a proof-of-concept randomized trial. Molecular autism vol 12 issue 1 2021 33536055 endocannabinoid dysfunction in animal models of autism spectrum disorder (asd) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this placebo-controlled double-blind comparison of two oral cannabinoid solutions in 150 participants (age 5-21\xc2\xa0years) with asd. 2021-09-24 2022-01-13 Not clear
William Fyke, Juan Marcos Alarcon, Milen Velinov, Kathryn K Chadma. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-\\xce\\xb1, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice. Autism research : official journal of the International Society for Autism Research vol 14 issue 7 2021 33886158 pharmacological inhibition of the primary endocannabinoid producing enzyme, dgl-\xce\xb1, induces autism spectrum disorder-like and co-morbid phenotypes in adult c57bl/j mice. 2021-08-12 2022-01-13 Not clear
Page: 
1   2   3